SYY Form 4: Hourican Receives RSUs and $80.98 Strike Options

Rhea-AI Filing Summary

Kevin Hourican, Chair and CEO of Sysco Corporation (SYY) reported equity transactions on Form 4. On 08/21/2025 he was granted 48,122 restricted stock units (RSUs) under the 2018 Omnibus Incentive Plan; one-third of those RSUs vest on 08/21/2026, 08/21/2027 and 08/21/2028. On 08/22/2025, 6,483 shares were withheld to satisfy tax withholding upon RSU vesting, leaving 468,500.053 shares beneficially owned after the transaction. The filing also discloses a grant of 128,039 stock options with an exercise price of $80.98; the options become exercisable in thirds on 08/21/2026, 08/21/2027 and 08/21/2028 and expire on 08/20/2035. All reported holdings are listed as direct beneficial ownership.

Positive

• 48,122 RSUs granted under the 2018 Omnibus Incentive Plan clearly documented
• 128,039 stock options granted with specified exercise price of $80.98 and defined expiration of 08/20/2035
• Vesting schedule disclosed: one‑third vesting on 08/21/2026, 08/21/2027 and 08/21/2028 for both RSUs and options
• Tax withholding executed (6,483 shares) upon RSU vesting, with resulting beneficial ownership reported

Negative

• None.

Insights

Securities/Compensation Analyst

TL;DR: CEO received RSUs and long‑dated options with staggered vesting; tax withholding occurred on vesting.

The Form 4 documents a routine executive equity award package: 48,122 RSUs granted and 128,039 stock options granted at a $80.98 strike price. Vesting for both awards occurs in three equal annual tranches beginning 08/21/2026 and options expire 08/20/2035. A subsequent withholding of 6,483 shares was executed to cover tax obligations. The filing shows direct beneficial ownership figures before and after the transactions, consistent with standard equity compensation reporting.

Corporate Governance Specialist

TL;DR: Transaction record is a standard disclosure of equity compensation for the company’s CEO, with clear vesting and withholding details.

The document provides explicit terms of the grants under the 2018 Omnibus Incentive Plan and the staggered vesting schedule for both RSUs and options. The exercise price and expiration date for options are specified, and tax withholding upon vesting is recorded. All holdings are reported as direct, and the form is signed by an attorney‑in‑fact, indicating procedural compliance with Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hourican Kevin

(Last) (First) (Middle)

1390 ENCLAVE PARKWAY

(Street)

HOUSTON TX 77077

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYSCO CORP [ SYY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		A		48,122(1)	A	$0(2)	474,983.053	D
Common Stock	08/22/2025		F		6,483(3)	D	$80.98	468,500.053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$80.98	08/21/2025		A		128,039		(4)	08/20/2035	Common Stock	128,039	$0(5)	128,039	D

Explanation of Responses:

1. Restricted stock units granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan.

2. One-third of the restricted stock units shall vest in equal installments on 08/21/2026, 08/21/2027 and 08/21/2028, respectively.

3. These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations.

4. One-third of the shares covered by the grant vest and are exercisable on 8/21/2026, 8/21/2027 and 8/21/2028, respectively. No options may be exercised prior to 8/21/2026. Options will expire on 8/20/2035.

5. Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan.

Remarks:

	/s/Boyd Chapin, Attorney-in-Fact	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Kevin Hourican (SYY) receive according to the Form 4?

The Form 4 reports a grant of 48,122 restricted stock units (RSUs) and 128,039 stock options with a $80.98 exercise price.

When do the RSUs and options granted to Kevin Hourican vest and expire?

Both RSUs and options vest in three equal tranches on 08/21/2026, 08/21/2027 and 08/21/2028. The options expire on 08/20/2035.

How many shares were withheld for taxes upon vesting?

6,483 shares were withheld on 08/22/2025 to satisfy tax withholding obligations.

What were Kevin Hourican’s reported beneficial ownership figures after these transactions?

After the RSU grant and subsequent withholding, the filing shows 468,500.053 shares beneficially owned. The filing also lists 128,039 derivative shares (options) beneficially owned.

Under which plan were the RSUs and options granted?

Both awards were granted pursuant to the 2018 Omnibus Incentive Plan as stated in the Form 4.